Companies · Other Health Care

SCSG EA Acquisition Company, Inc.

NASHVILLE · Other Health Care

Diligence memoA one-page analyst read on SCSG EA Acquisition Company, Inc. — recommendation, valuation, rhythm, risks.
$155.6M
Total raised · real
4
Rounds
0.0×
Latest step-up
Top 3%
Sector rank · raised
Series D+
Latest stage · inferred · Wed Aug 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

SCSG EA Acquisition Company, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.00× the median modeled value of Series D+ Other Health Care companies in 2013–2015 (16 peers) — value vs value, same stage and era.
Dormant
  • Last raise 12.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

SCSG EA Acquisition Company, Inc. is one of 5377 Other Health Care companies tracked from NASHVILLE. By capital raised it ranks among the largest (ahead of 98% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$1.3B$2.5B$3.8B$5.0BSeries B · 2009-05-13 Raised $20M (real) Modeled valuation $443M (est)$20M$443MSeries B2009Series B · 2010-07-01 Raised $12M (real) Modeled valuation $266M (est)$12M$266MSeries B2010Series B · 2010-07-01 Raised $12M (real) Modeled valuation $266M (est)$12M$266MSeries B2010Series D+ · 2011-05-18 Raised $123M (real) Modeled valuation $2.8B (est)$123M$2.8BSeries D+2011Series D+ · 2013-08-07 Raised $570K (real) Modeled valuation $13M (est)$570K$13MSeries D+2013+$12M+$12M+$123M+$570KCumulative $168M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$20.0M · 2009
Series B extension$12.0M · 2010
Series B extension$12.0M · 2010
Series D+$123.0M · 2011no Series C on file
Series D+ extension$570K · 2013

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series C — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$13.1M
Base estimate est.
$3.0M
Conservative case
$28.7M
Upside case
$4.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series D+a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $443.1M · 2009-05-132009Series B · modeled $265.9M · 2010-07-01Series B · modeled $265.9M · 2010-07-01Series D+ · modeled $2.8B · 2011-05-18Series D+ · modeled $13.1M · 2013-08-072013
Model inputs · modeled:benchmark-stage-stepup-v1
12%
Dilution assumption
Implied ownership sold in the financing.
80%
Survival probability
64% low · 88% high
1.23×/yr
Annual markup
1.38×/yr upside case
6.0 yr
Elapsed time used
12.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
13 mo
Avg between rounds
$36.7M/yr
Capital velocity
17.1 yr
On record since
2009
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 64× above median
This company$155.6M
Sector median$2.4M
Latest round — vs other Series D+ rounds in sector (real $, this stage) 0.0× of median
This company$570K
Sector median$123.0M
Modeled value — vs sector median (estimate, all stages) 0.6× of median
This company$13.1M
Sector median$22.1M

Raised more than 98% of sector peers (real $). Modeled value above 40% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #15 of 16.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$10.0B$100.0B$10.0M$100.0M$1.0BCapital raised (log)Onex TSG Holdings Corp. · Series D+ Raised $336.0M · modeled $7.7B (est)BVO Holdings, LLC · Series D+ Raised $335.8M · modeled $7.7B (est)Mdp Hc Holdings, Llc · Series D+ Raised $310.1M · modeled $7.1B (est)Amsurg Corp · Series D+ Raised $270.9M · modeled $6.2B (est)Greatbatch, Inc. · Series D+ Raised $247.2M · modeled $5.7B (est)Hc Group Holdings Iii, Inc. · Series D+ Raised $144.3M · modeled $3.3B (est)Diplomat Pharmacy, Inc. · Series D+ Raised $140.0M · modeled $3.2B (est)Proteus Biomedical Inc · Series D+ Raised $162.4M · modeled $2.7B (est)Mmi Holdings Inc · Series D+ Raised $109.0M · modeled $2.5B (est)Evolent Health LLC · Series D+ Raised $221.3M · modeled $2.3B (est)BioScrip, Inc. · Series D+ Raised $172.5M · modeled $1.4B (est)Envision Rx Options Holdings, Inc. · Series D+ Raised $144.5M · modeled $80.0M (est)SCSG EA Acquisition Company, Inc. (this company) Raised $155.6M · modeled $13.1M (est)SCSG EA Acquisition Company, Inc.
CompanyStageRaised · realValue · estvs peer med.
Onex TSG Holdings Corp.Series D+$336.0M$7.7B2.94×
BVO Holdings, LLCSeries D+$335.8M$7.7B2.94×
Mdp Hc Holdings, LlcSeries D+$310.1M$7.1B2.71×
Amsurg CorpSeries D+$270.9M$6.2B2.37×
Greatbatch, Inc.Series D+$247.2M$5.7B2.16×
Hc Group Holdings Iii, Inc.Series D+$144.3M$3.3B1.26×
Diplomat Pharmacy, Inc.Series D+$140.0M$3.2B1.23×
Proteus Biomedical IncSeries D+$162.4M$2.7B1.05×
Mmi Holdings IncSeries D+$109.0M$2.5B0.95×
Evolent Health LLCSeries D+$221.3M$2.3B0.89×
BioScrip, Inc.Series D+$172.5M$1.4B0.55×
Envision Rx Options Holdings, Inc.Series D+$144.5M$80.0M0.03×
SCSG EA Acquisition Company, Inc. this companySeries D+$155.6M$13.1M0.00×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$20.0M2009-05-13$111.1M$443.1M90%
Series B$12.0M2010-07-01$66.7M$265.9M90%
Series B$12.0M2010-07-01$66.7M$265.9M90%
Series D+$123.0M2011-05-18$1.0B$2.8B90%
Series D+$570K2013-08-07$4.7M$13.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$20.0M2009-05-13
    • First recorded raise — entered as Series B.
  2. Series B$12.0M2010-07-01
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
  3. Series B$12.0M2010-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  4. Series D+$123.0M2011-05-18
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 10.3× larger than the prior — scaling up.
  5. Series D+$570K2013-08-07
    • Raised again after 27 mo — slower than the ~14 mo sector norm.
    • Round 215.8× smaller than the prior — bridge or down round.
Intelligence
2014 ~Q3
Modeled next raise · ~13mo cadence
$570K
Modeled next size est.range $570K$912K
0.0×
Last step-up
$36.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Fitzgerald6 other2009-05
Jonathan Walker3 other2011-05
David Maloney2 other2009-05
Harry Jacobson2 other2010-07
Michael Kluger2 other2009-05
Michael Mauldin2 other2009-05
Bill J. Elliott2013-08
Christi Griffin2009-05
David C. Head2013-08
David Horing2011-05
David J. Horing2013-08
David M. Maloney2013-08
D. Christopher Wells2013-08
Gary Brukardt2009-05
Helen J. Chiang2013-08
James C. Lordeman2013-08
Jeffrey Christopher Gray2013-08
J. Michael Mauldin2013-08
Marc J. Saiontz2013-08
Mark Saiontz2011-05
Melvin Hall2011-05
Melvin J. Hall2013-08
Phil Green2010-07
Phil Greene2009-05
Registry & provenance

SCSG EA Acquisition Company, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1464798
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Urgent Team Holdings, Inc.Other Health CareSeries B$61.5M$163.5Mnetwork2 shared operators · same sector
Clinipace IncOther Health CareSeries B$122.3M$85.9Mnetwork1 shared operator · same sector
SUN Behavioral HoldCo, LLCOther Health CareSeries C$65.2M$1.1Bnetwork1 shared operator · same sector
Abs Topco, LlcOther Health CareSeries B$25.5M$34.2Mnetwork1 shared operator · same sector
OurPharma Holdings LLCOther Health CareSeries A$15.9M$825Knetwork1 shared operator · same sector
Oliver Street Dermatology Holdings LLCOther Health CareSeries C$109.7M$13.1Msame sector
electroCore, Inc.Other Health CareSeries C$87.3M$11.0Msame sector
Light Wave Holding Company, LLCOther Health CareSeries B$82.9M$11.7Msame sector
Frequently asked
How much funding has SCSG EA Acquisition Company, Inc. raised?
SCSG EA Acquisition Company, Inc. has raised approximately $155.6M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is SCSG EA Acquisition Company, Inc.'s estimated valuation?
Provath's modeled valuation for SCSG EA Acquisition Company, Inc. is approximately $13.1M (modeled range $3.0M–$28.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is SCSG EA Acquisition Company, Inc. at?
SCSG EA Acquisition Company, Inc.'s latest modeled financing stage is Series D+. Its most recent recorded round closed around Wed Aug 07.
What does SCSG EA Acquisition Company, Inc. do and where is it based?
SCSG EA Acquisition Company, Inc. operates in the Other Health Care sector, based in NASHVILLE.
Explore related

See where SCSG EA Acquisition Company, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at SCSG EA Acquisition Company, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.